. Mild hypoxia impairs alveolarization in the endothelial nitric oxide synthase-deficient mouse. Am J Physiol Lung Cell Mol Physiol 284: L964-L971, 2003. First published February 14, 2003 10.1152/ajplung.00421.2002In addition to its vasodilator properties, nitric oxide (NO) promotes angiogenesis in the systemic circulation and tumors. However, the role of NO in promoting normal lung vascular growth and its impact on alveolarization during development or in response to perinatal stress is unknown. We hypothesized that NO modulates lung vascular and alveolar growth and that decreased NO production impairs distal lung growth in response to mild hypoxia. Litters of 1-day-old mouse pups from parents that were heterozygous for endothelial nitric oxide synthase (eNOS) deficiency were placed in a hypobaric chamber at a simulated altitude of 12,300 ft (FIO 2 ϭ 0.16). After 10 days, the mice were killed, and lungs were fixed for morphometric and molecular analysis. Compared with wild-type controls, mean linear intercept (MLI), which is inversely proportional to alveolar surface area, was increased in the eNOS-deficient (eNOS Ϫ/Ϫ) mice [51 Ϯ 2 m (eNOS Ϫ/Ϫ) vs. 41 Ϯ 1 m (wild type); P Ͻ 0.01]. MLI was also increased in the eNOS heterozygote (ϩ/Ϫ) mice (44 Ϯ 1 m; P Ͻ 0.03 vs. wild type). Vascular volume density was decreased in the eNOS Ϫ/Ϫ mice compared with wild-type controls (P Ͻ 0.03). Lung vascular endothelial growth factor (VEGF) protein and VEGF receptor-1 (VEGFR-1) protein content were not different between the study groups. In contrast, lung VEGFR-2 protein content was decreased from control values by 63 and 34% in the eNOS Ϫ/Ϫ and eNOS ϩ/Ϫ mice, respectively (P Ͻ 0.03). We conclude that exposure to mild hypoxia during a critical period of lung development impairs alveolarization and reduces vessel density in the eNOS-deficient mouse. We speculate that NO preserves normal distal lung growth during hypoxic stress, perhaps through preservation of VEGFR-2 signaling. pulmonary hypertension; persistent pulmonary hypertension of the newborn; lung hypoplasia; congenital diaphragmatic hernia; angiogenesis PREMATURE BIRTH, PERINATAL STRESS, and the treatment of neonatal respiratory distress syndrome (RDS) can cause lung injury, leading to the development of chronic lung disease of infancy, known as bronchopulmonary dysplasia (BPD) (37). Although mechanisms that cause BPD are not completely understood, surfactant deficiency, ventilator-induced lung injury, oxygen toxicity, inflammation, and infection have been identified as important pathogenic factors (21). More recently, the routine use of exogenous surfactant therapy has reduced the severity of acute lung disease in premature neonates, but the incidence of BPD continues to rise (22). Lung histology of infants and older children who die from BPD demonstrate striking inhibition of distal lung growth (1, 19, 32, 42, 44) . Impaired alveolarization and dysmorphic vascular growth decrease lung surface area, resulting in abnormal gas exchange, exercise intolerance, and pulmonary hypertension in patients with BPD (1, 22). Mechanisms that disrupt alveolarization and angiogenesis resulting in the development of BPD are only beginning to be understood.
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The saccular and alveolar phases of lung development are characterized by rapid increases in vessel growth and septation within the distal air space. These phases of lung development occur from 24 wk of gestation through the first 3 yr of life in humans and during the first 3 wk of postnatal life in rodents (7, 33) . Lung development is dependent on interactions between developing vessels and air spaces (4, 15, 40) and is a highly complex process dependent on a temporal and spatial expression of multiple cytokines, growth factors, growth factor receptors, and other signals (35, 39, 45) . Septation and the formation of alveoli late in gestation are intricately linked with angiogenesis as reflected by the findings that inhibition of angiogenesis impairs alveolarization (20) . Likewise, hypoxic exposure during critical periods of lung development can disrupt both alveolar and pulmonary vascular growth (33, 46) . Mechanisms that link alveolar development and vessel growth are uncertain.
Vascular endothelial growth factor (VEGF) is a potent mitogen for angiogenesis (13) that plays an important role during fetal lung development. VEGF exists as multiple isoforms and induces vascular growth and angiogenesis through the activation of its receptors VEGFR-1 (flt-1) and VEGFR-2 (KDR/flk-1) (36, 49) . Lung VEGF mRNA and protein are decreased in human neonates who die with BPD (5, 27) , and treatment of newborn rats with a VEGFR inhibitor reduces vessel density and alveolarization in infant and adult rats (20, 30) . These studies suggest that disruption of VEGF signaling can impair vessel growth and alveolarization and may contribute to abnormal lung structure in infants with BPD.
In studies of systemic vessels and tumors, VEGF stimulates angiogenesis by the elaboration of nitric oxide (NO) through activation of endothelial nitric oxide synthase (eNOS) (12) . VEGF activates eNOS in endothelial cells via its interaction with VEGFR-2 (26, 41) , and the proangiogenic effect of VEGF in the systemic circulation is partly dependent on eNOS activity (14) . Whether VEGF-induced angiogenesis is dependent on eNOS activity in the developing lung is uncertain. In different settings, NO has been reported as having both proangiogenic (14, 34) and antiangiogenic effects (38) . The role of eNOS during postnatal lung vascular growth and its role in the response to injury, such as hypoxia, has not been directly studied.
On the basis of these past studies, we hypothesized that NO modulates lung vascular and alveolar growth and that decreased NO production impairs distal lung growth in response to mild postnatal hypoxia. To test this hypothesis, we studied the effects of mild hypobaric hypoxia (16% oxygen) in mice that are genetically deficient in eNOS. We report that although eNOS deficiency did not affect alveolarization in infant mice raised in room air, mild hypoxia impaired alveolarization and reduced vessel density in eNOS-deficient mice.
METHODS
Study animals and protocols. All procedures and protocols were reviewed and approved by the Animal Care and Use Committee at the University of Colorado Health Sciences Center. Mice (C57/B6) that were genetically engineered to be heterozygous for a deficiency of eNOS (18) were obtained from Jackson Laboratories. Genomic DNA was isolated from tails of experimental animals. Genotyping was done by PCR, utilizing previously described primers to identify the presence of the Neo gene insert in the eNOS gene (18) .
Exposure of neonatal mice to mild hypoxia. Males and females known to be heterozygous for eNOS deficiency were bred to ensure that the generation of litters were homozygous and heterozygous for eNOS deficiency and wild type. The litters of heterozygote ϫ heterozygote matings were delivered and allowed to recover for 24 h. Mothers and litters were either treated in hypobaric chambers at a simulated altitude of 12,300 ft (16% O 2; PO2 ϭ 90 mmHg) for 10 days or maintained in room air. Exposure to hypoxia was continuous with less than a 1-h/day interruption for animal care. After 10 days, total body weight was measured on each animal, and lung tissue was collected from the studies below.
Tissue for histological analysis. Animals were killed with intraperitoneal injections of pentobarbital (100 mg/kg). A catheter was placed into the trachea, and the lungs were inflated at 30 cmH 2O pressure with 4% paraformaldehyde in RNase-free phosphate-buffered saline (PBS) and maintained under constant pressure for at least 45 min. A ligature was tightened around the trachea to maintain pressure, and then tracheal cannula was removed. The lungs were immersed in paraformaldehyde solution overnight. The right lower lobe was embedded in paraffin, and sections were obtained with a microtome set at 5 m. Sections were mounted on RNase-free slides for histochemical analysis.
Morphometric analysis. Six lung sections from each animal were selected for study in an unbiased fashion. The orientation of these samples was at random, creating isotropic uniform random plane sections of the lung tissue. Each section was stained with hematoxylin and eosin. Images of each section were captured using the ϫ20 objective as a highresolution PICT image by a ProgRes 3008 digital camera (JenOptik; 1,928 ϫ 1,450 pixel resolution) and were analyzed with the use of Stereology Toolbox software (Davis, CA). The intra-alveolar distance was measured as the mean linear intercept (MLI), which was determined by dividing the total length of 42 lines drawn across the lung section by the number of intercepts encountered as determined by the investigator (48) . The investigator was blinded to the identity of the sections at the time of analysis. Lines that crossed large airways or vessels were excluded from analysis. MLI is inversely proportional to the surface area of the lung (47, 48) . Radial alveolar counts (RAC) were assessed by the methods of Cooney and Thurlbeck and Emery and Mithal (11) . Sections were also stained for the presence of factor VIII (Dako), an endothelial-specific marker. A point-counting method was used to determine the volume fraction [or vessel volume density (V v)] of immunoreactive sites in which the lung parenchyma served as the volume of reference (10, 17) . A grid of 100 points was superimposed on color photographs taken using the ϫ20 objective from seven random noncontiguous fields per animal. The number of points falling on immunoreactive sites and on lung parenchyma was recorded. Lung parenchyma was defined as parenchymal tissue excluding large vessels and airways. The Vv was calculated as the ratio of the number of points falling on factor VIII sites to points on lung parenchyma.
Western blot analysis. Frozen lung samples were homogenized in ice-cold buffer containing 50 mM Tris ⅐ HCl (pH 7.4), 1 mM EDTA, 1 mM EGTA, 0.1% 2-mercaptoethanol, 1 mM 4-(2-aminoethyl)benzenesulfonyl fluoride, 1 M leupeptin, and 1 M pepstatin A. The samples were centrifuged at 1,500 g for 20 min at 4°C to remove cellular debris. Protein content in the supernatant was determined by the Bradford method (6) using bovine serum albumin as the standard. Briefly, 25 g of protein sample per lane were resolved by SDS-PAGE, and proteins from the gel were transferred to nitrocellulose membrane. Blots were blocked 1 h in 5% nonfat dry milk in Tris-buffered saline (TBS) with 0.1% Tween 20. These blots were incubated for 1 h at room temperature with either rabbit anti-human polyclonal VEGF antibody (sc-152; Santa Cruz Biotechnology), rabbit anti-mouse polyclonal VEGFR-1 (Flt-1) antibody (sc-504; Santa Cruz Biotechnology), or rabbit anti-human polyclonal VEGFR-2 antibody (KDR/flk-1; sc-316; Santa Cruz Biotechnology) diluted 1:200 in 5% nonfat dry milk in TBS with 0.1% Tween 20. Blots were incubated for 1 h at room temperature with a goat anti-rabbit IgGhorseradish peroxidase antibody (Santa Cruz Biotechnology). After being washed, bands were visualized by enhanced chemiluminescence (ECL Plus kit; Amersham Pharmacia Biotech, Little Chalfont, UK). Adult mouse lung homogenate was run as a control, and the band that comigrated with the molecular size as identified by the manufacturer for the protein of interest was quantified by densitometry for VEGFR-1 and VEGFR-2. For Western blot analysis of VEGF, recombinant mouse VEGF was used as a control. Densitometry was performed using NIH Image (v. 1.61).
Immunohistochemical staining. Lungs were fixed in 4% paraformaldehyde for 24 h and then stored in 70% ethanol. The left lower lobe was embedded in paraffin, cut into 5-mthick sections, and mounted on "plus" slides. Slides were deparaffinized in HemoDe and rehydrated by serial immersions in 100% ethanol, 95% ethanol, 70% ethanol, and 100% water. Proteinase K (50 g/ml) was placed on the sections for 5 min. The sections were washed with 1ϫ PBS (2.7 mM KCl, 1.2 mM KH 2PO4, 138 mM NaCl, 8.1 mM Na2HPO4). Endogenous peroxidase activity was quenched by immersion in 3% hydrogen peroxide in methanol. The slides were rinsed with 1ϫ PBS. The sections were incubated with 10% goat/2% mouse serum and rabbit anti-human polyclonal factor VIII antibody (DAKO, A0082) or mouse IgG diluted 1:1,000 in 1ϫ PBS with 1% BSA and 0.1% sodium azide for 1 h at room temperature. After incubation, the sections were rinsed with 1ϫ PBS, incubated in 10% goat/2% mouse serum for 5 min, and then incubated with biotin-labeled goat anti-mouse secondary antibody diluted 1:200 in 10% goat/2% sheep serum for 15 min at room temperature. After incubation with the secondary antibody, sections were rinsed with 1ϫ PBS. Sections were incubated with ABC complex (Vector) for 30 min at room temperature, rinsed in 1ϫ PBS, and developed with diaminobenzidine (DAB) and hydrogen peroxide. Washing with water stopped the DAB reaction. A light hematoxylin counterstain was applied. Sections were dehydrated by sequential immersion in 70% ethanol, 95% ethanol, and 100% ethanol and then in HemoDe before a coverslip was placed on the section.
Statistical analysis. Data are presented as means Ϯ SE. Statistical analysis was performed with the Statview software package (SAS Institute, Cary, NC). Statistical comparisons were made using analysis of variance and Fisher's protected least significant differences test. P Ͻ 0.05 was considered significant.
RESULTS
Body weight. At 11 days postnatal age, body weight was not different between wild-type, eNOS heterozygote (eNOS ϩ/Ϫ), and eNOS-deficient (eNOS Ϫ/Ϫ) mice raised in room air. Of the mice raised in 16% oxygen, body weight of the eNOS Ϫ/Ϫ was significantly lower than eNOS ϩ/Ϫ and wild-type mice (Table 1 , P Ͻ 0.01). Within each study group, body weights of the animals raised in 16% oxygen were significantly lower than those raised in room air (Table 1 , P Ͻ 0.01).
Lung histology and morphometric studies. There was no significant change in MLI between wild-type, eNOS ϩ/Ϫ, or eNOS Ϫ/Ϫ animals raised in room air. Compared with wild-type animals, eNOS Ϫ/Ϫ animals raised in 16% oxygen had enlarged distal airspaces (Fig. 1) . After exposure to mild hypoxia, the MLI in the eNOS Ϫ/Ϫ mice was increased by 25% compared with the MLI measurements in the wild-type mice (52 Ϯ 2.0 m vs. 41 Ϯ 1 m; P Ͻ 0.01; Fig. 2) . MLI in the eNOS ϩ/Ϫ mice raised in 16% oxygen was increased by 6% compared with wild-type mice (44 Ϯ 1 m; P Ͻ 0.03; Fig. 2 ). MLI of wild-type mice raised in room air was not different compared with those raised in 16% oxy- Values are means Ϯ SE; the number of mice is shown in parentheses. * P Ͻ 0.01 vs. wild-type and eNOS ϩ/Ϫ mice raised in 16% oxygen. All weights of mice raised in 16% oxygen were significantly less than those raised in normoxia, P Ͻ 0.01. Fig. 1 . Lung histology of wild-type (ϩ/ϩ) and endothelial nitric oxide synthase (eNOS)-deficient (Ϫ/Ϫ) infant mice after exposure to normoxia or mild hypoxia (FIO 2 ϭ 0.16) for 10 days. As shown, mild hypoxia decreases lung complexity in the eNOS Ϫ/Ϫ mice but not in wild-type controls. Magnification, ϫ200.
gen (42 Ϯ 1 m; P ϭ not significant; Fig. 2 ). There was no difference in the RAC between the three groups of animals raised in room air. There was a 42% decrease in RAC in the eNOS Ϫ/Ϫ mice raised in mild hypoxia compared with wild-type mice (4.13 Ϯ 0.24 vs. 7.14 Ϯ 0.14; P Ͻ 0.01; Fig. 3 ). The RAC of eNOS ϩ/Ϫ mice was reduced by 13% compared with wild-type mice (6.23 Ϯ 0.19; P Ͻ 0.01; Fig. 3 ). There was no difference in the RAC of wild-type animals raised in room air compared with those raised in 16% oxygen. There were no differences in V v between the three groups of animals raised in room air. Lung V v in the eNOS Ϫ/Ϫ mice raised in 16% oxygen was decreased compared with values measured in wild-type mice (69 Ϯ 3 vs. 75 Ϯ 2%; P Ͻ 0.03; Fig. 4) .
Effects of mild hypoxia on lung VEGF, VEGFR-1, and VEGFR-2 expression.
As determined by Western blot analysis, we detected no differences in lung VEGF protein in the eNOS Ϫ/Ϫ, eNOS ϩ/Ϫ, and wild-type mice when raised in room air or 16% oxygen (Fig. 5) . Lung VEGFR-1 protein expression in the eNOS Ϫ/Ϫ and eNOS ϩ/Ϫ mice was not different from measurements in wild-type mice that were raised in room air or 16% oxygen (Fig. 6 ). In addition, lung VEGFR-2 expression was not different between genotypes raised in room air. However, compared with wild-type controls, 16% oxygen exposure decreased VEGFR-2 protein by 63 and 33% in eNOS Ϫ/Ϫ and ϩ/Ϫ mice, respectively (P Ͻ 0.03 for each vs. controls; Fig. 7 ).
DISCUSSION
We report that in contrast to wild-type mice, exposure to mild hypoxia (16% oxygen) impairs alveolarization in eNOS-deficient mice, as evidenced by an increase in MLI, which is inversely proportional to the internal lung surface area, and reduced RAC, in addition to decreased vascular volume density. In infant mice raised in room air, alveolarization is not reduced in eNOS-deficient mice, and mild hypoxia (16% oxygen) has no apparent effect on alveolarization in wild-type mice. We also report that mild hypoxia does not affect lung VEGF protein expression but reduces VEGFR-2 protein expression by 63% in eNOS Ϫ/Ϫ mice. These findings suggest that with mild hypoxic stress in the early postnatal period, eNOS deficiency impairs angiogenesis and alveolar development. These findings also suggest that NO production plays an important role in modulating distal lung growth in response to mild stress. This is the first study to report the effects of mild neonatal hypoxia on pulmonary vascular and alveolar development in animals with primary eNOS deficiency. Although alveolarization and lung vascular growth are not apparently affected by mild postnatal . MLI is increased in the eNOS-deficient (Ϫ/Ϫ) and eNOS-heterozygous (ϩ/Ϫ) mice exposed to 16% hypoxia compared with wild-type (ϩ/ϩ) mice (*P Ͻ 0.03). There is no difference in MLI between study groups raised in room air, and the MLI was not increased after exposure to 16% oxygen in wild-type mice. Fig. 3 . Radial alveolar counts (RAC) of 11-day-old mice raised in 16% oxygen (closed bars) and room air (open bars). RAC is increased in the eNOS-deficient (Ϫ/Ϫ) and eNOS-heterozygous (ϩ/Ϫ) mice exposed to 16% hypoxia compared with wild-type (ϩ/ϩ) mice (*P Ͻ 0.01). There is no difference in RAC between study groups raised in room air, and the RAC was not increased after exposure to 16% oxygen in wild-type mice. Fig. 4 . Vessel volume density (Vv) in wild-type (ϩ/ϩ), eNOS-heterozygous (ϩ/Ϫ), and eNOS-deficient (Ϫ/Ϫ) mice. As shown, Vv is decreased after exposure to mild hypoxia (16% oxygen) (P Ͻ 0.03).
L967
NO DEFICIENCY IMPAIRS ALVEOLARIZATION hypoxia, mice with a genetic deficiency of eNOS have an increased susceptibility for abnormal lung growth in response to mild postnatal hypoxia. Our findings are consistent with a recent report of impaired compensatory lung growth after pneumonectomy in adult mice with eNOS deficiency (31) . These changes consist of alveolar simplification and decreased vessel density, which are similar to the lung pathology of infants with BPD (1, 22) . Interestingly, the expression of a potent angiogenic growth factor, VEGF, is unchanged in the hypoxic eNOS-deficient mouse, but lung expression of VEGFR-2, the primary receptor involved in VEGFstimulated angiogenesis, is decreased. These results suggest that eNOS contributes to the maintenance of normal lung vascular and alveolar growth in response to mild postnatal hypoxic stress. We further speculate that this mechanism may be partially through the preservation of VEGF signaling via increased VEGFR-2 expression.
We have observed a decrease in body weight in eNOS Ϫ/Ϫ mice exposed to mild hypoxia, which correlates with previous studies that have observed a reduction in size (both weight and crown-rump length) of eNOS Ϫ/Ϫ mice (16) . This previous study suggests that the reduction in size of the eNOS Ϫ/Ϫ mice was not from malnutrition but may be secondary to abnormalities of somatic growth from the eNOS deficiency. The role of malnutrition on alveolar growth and development is well described (2, (23) (24) (25) . If the abnormalities of alveolarization that we report were solely due to a reduction in body weight as a consequence of the eNOS deficiency, then we would expect that these abnormalities in alveolarization would be seen in eNOS Ϫ/Ϫ animals raised in room air. This study did not quantify other measures of growth, such as crown-rump length, and we cannot exclude that undernutrition may play a role in the abnormalities of lung growth that we have observed.
Previous reports of the effects of hypoxia on lung structure have generally studied the response of the developing lung to more severe hypoxia (33, 46) . Postnatal exposure of infant rats to 13% oxygen during the first 2 wk of life results in abnormal lung development, characterized by impaired septation and decreased surface area for gas exchange (33) . Brief perinatal hypoxia (10% oxygen) during the last 3 days of gestation and for the first 3 days of life decreases alveolar septation and vessel density in infant rats, which persists into adulthood (46) . These studies illustrate that hypoxic exposure during critical periods of lung devel- opment disrupts alveolar and pulmonary vascular structure.
A link between vascular growth and alveolarization has been previously demonstrated through studies with inhibitors of angiogenesis, including fumagillin, thalidomide, and SU-5416 (a VEGFR inhibitor). Treatment with these agents impairs alveolarization in infant and adult rats (20, 30) . We have also observed a reduction in alveolarization and pulmonary arterial density in response to mild hypoxia in a genetic model of pulmonary hypertension, the Fawn-Hooded rat (FHR) (28) . The FHR strain is characterized by decreased lung eNOS expression in fetal and neonatal life (29) . Interestingly, treatment of FHR with low levels of supplemental oxygen improves vessel density and alveolarization, suggesting that the genetic abnormality in the FHR increases the susceptibility for abnormal lung development with stress (29) . Still, the exact genetic abnormality in the FHR is unknown, and the FHR has been known to have abnormalities in serotonin and endothelin pathways (3, 43, 50, 52) , which may also contribute to the abnormal adaptation to hypoxia in the FHR.
Angiogenesis is a complex process that requires endothelial cell proliferation, migration, and vascular tube formation (9, 39) . VEGF is a potent growth factor for endothelial cell proliferation, survival, and angiogenesis (36) . Previous studies have shown that specific inhibition of VEGFRs during the neonatal period resulted in a decrease in alveolarization and pulmonary arterial density (20, 30) . NO is a downstream effector of VEGF via VEGF/VEGFR-2 phosphorylation and activation of eNOS (12, 14, 26, 41) . In the systemic circulation, VEGF-mediated angiogenesis in wound healing is dependent on functional eNOS, as shown by a reduction in VEGF-induced angiogenesis in the eNOS-deficient mouse (14) . In the ischemic hindlimb model, eNOS-deficient mice did not increase angiogenesis in response to VEGF, further evidence that eNOS is a downstream mediator of VEGF (34) . VEGF signaling that results in endothelial cell proliferation is via an upregulation of VEGFR-2 that is dependent on NO (51) . NO plays a role in VEGF/VEGFR-1 signaling that is responsible for the formation of mature vascular structures. Selective inhibition of VEGFR-1 results in the formation of abnormal aneurysm-like structures and accumulation of endothelial cells, and this effect was rescued by NO donors (8) . These studies suggest that normal endothelial cell proliferation and differentiation into vascular structures in response to VEGF is dependent on functional eNOS. Whereas our study suggests that the eNOS is not essential for normal lung vascular and alveolar development at ambient oxygen tension, functional eNOS is critical for normal lung vascular and alveolar development during hypoxic stress.
Potential limitations of our study include that abnormalities in expression of other growth factors and receptors may be affected by eNOS deficiency, and these may contribute to abnormalities of lung angiogenesis and alveolarization. We did not measure absolute changes in NO production in these animals, and it is possible that there were compensatory increases in the other NOS isoforms (type I and type II) that may have compensated for the lack of eNOS. Further studies will need to be performed to see whether exogenous NO can rescue this phenotype. We were not able to measure lung compliance and elastic recoil in these animals, and changes in these could lead to abnormal air space size and a reduction in secondary septal height. Future studies are needed to assess these measures of lung function in these animals. Further studies will need to be performed to elucidate the specific mechanisms by which a deficiency of eNOS affects endothelial cell growth, migration, and differentiation. Finally, a deficiency of eNOS may have effects on prenatal lung vascular and air space development that may predispose this genetic model from adapting to mild hypoxic exposure.
In summary, exposure to mild hypoxia in the eNOSdeficient mouse results in abnormalities of pulmonary angiogenesis and alveolarization, as evidenced by a reduction in alveolar surface area for gas exchange and a decreased vascular volume density. Furthermore, this phenomenon is not observed during development at normal ambient oxygen tension. These mice show no (16% oxygen; B) . Lung VEGFR-2 was decreased by 63 and 33% in the eNOS deficient (Ϫ/Ϫ) and eNOS-heterozygous (ϩ/Ϫ) mice, respectively, compared with wild-type (ϩ/ϩ). *P Ͻ 0.03; # P Ͻ 0.01. change in VEGF and VEGFR-1 expression but show a decrease in VEGFR-2 expression compared with wildtype mice. We speculate that NO is essential in pulmonary angiogenesis and alveolarization in the postnatal lung during mild hypoxic stress through the preservation of VEGF signaling via increasing VEGFR-2 expression.
